EXAGEN INC. - COMMON STOCK

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

11 May 2022 16:06:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2022 Results

11 May 2022 16:05:01 By Nasdaq GlobeNewswire

Exagen Announces Five-Week Campaign for Lupus Awareness Month

01 May 2022 12:00:00 By Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

25 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

20 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

30 Mar 2022 08:25:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

22 Mar 2022 16:06:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

22 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

16 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

09 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

08 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

09 Jan 2022 12:00:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

17 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2021 Results

10 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum

04 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021

27 Oct 2021 16:05:01 By Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus

27 Oct 2021 08:25:00 By Nasdaq GlobeNewswire

Exagen Inc. Announces $27.2 Million Debt Refinancing

25 Oct 2021 08:25:00 By Nasdaq GlobeNewswire

Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021

21 Oct 2021 16:05:00 By Nasdaq GlobeNewswire